https://www.linkedin.com/jobs/view/3625912321/
Pharmacoviligance Scientist, Liège
We are seeking a motivated Pharmacovigilance Scientist to join our team and support our growth.
You will support the clinical trial program and post-market expansion in EU & UK as well as ongoing PV activities and supporting Medical Information operations
Key Responsibilities:
Manage Telix clinical trial programme's Clinical Safety activities, including SAE handling, database entry, narrative writing, and MedDRA coding.
Support post market aggregate report activities and ensure submission compliance.Handle medical information requests, tracking, and assignment.
Assist EU and UK QPPVs in maintaining essential documentation.
Maintain departmental quality documentation and provide training on safety reporting and medical information requests.
Education And Experience
You have 2 to 4 years' experience as PV,
You have case processing experience in PM and CT setting essential,
Already aggregate report writing, safety agreements and working with vendors would be considered as an asset
Working experience or knowledge of medical information activities would also be an asset
Fluent in English
Ability and willingness to work collaboratively with global team members across multiple time zones
- Forums
- ASX - By Stock
- TLX
- Ann: Illuccix European Marketing Authorisation Application Update
Ann: Illuccix European Marketing Authorisation Application Update, page-28
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$23.47 |
Change
0.130(0.56%) |
Mkt cap ! $7.855B |
Open | High | Low | Value | Volume |
$23.82 | $23.99 | $23.23 | $28.94M | 1.231M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2801 | $23.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$23.50 | 7000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2801 | 23.460 |
1 | 1000 | 23.450 |
1 | 2678 | 23.410 |
2 | 970 | 23.390 |
1 | 2678 | 23.380 |
Price($) | Vol. | No. |
---|---|---|
23.500 | 7000 | 1 |
23.580 | 1470 | 3 |
23.590 | 2678 | 1 |
23.620 | 5178 | 2 |
23.630 | 7680 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online